Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Innovent Biologics, Inc. IVBXF

Set alert

Price alert · IVBXF

All alert types
9.90 USD -1.40 -12.39%

At close · Oct 30

10.60 Day range 10.60
9.10 52-week range 15.01
YTD
+1.54%
1 year
-4.26%
Open
10.60
Prev close
11.30
Mkt cap
17.26B
Vol
275
Avg vol
1.97K
EPS
0.09
P/E
110.00
More statistics
Low
10.60
High
10.60
Earnings
Aug 26, 2026

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for IVBXF has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

3.86 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 3
  • Return on Assets 3
  • Debt / Equity 3
  • P/E 1
  • P/B 1

Valuation

P/E 145×
FY 2016: -48.7×FY 2017: -41.0×FY 2018: -1.3×FY 2019: -15.7×FY 2020: -90.4×FY 2021: -20.8×FY 2022: -20.2×FY 2023: -52.9×FY 2024: -565×FY 2025: 145×
FY 2016 5y median -20.8× FY 2025
P/S 9.0×
FY 2016: 762×FY 2017: 1238×FY 2018: 766×FY 2019: 26.6×FY 2020: 23.5×FY 2021: 13.3×FY 2022: 9.7×FY 2023: 8.8×FY 2024: 5.5×FY 2025: 9.0×
FY 2016 5y median 9.0× FY 2025
P/B 5.9×
FY 2016: -17.7×FY 2017: -11.8×FY 2018: 1.7×FY 2019: 5.9×FY 2020: 10.3×FY 2021: 5.5×FY 2022: 4.1×FY 2023: 4.3×FY 2024: 3.9×FY 2025: 5.9×
FY 2016 5y median 4.3× FY 2025
P/FCF 12.3×
FY 2016: -58.1×FY 2017: -39.3×FY 2018: -5.5×FY 2019: -13.7×FY 2020: -83.6×FY 2021: -14.6×FY 2022: -13.3×FY 2023: -44.1×FY 2024: -124×FY 2025: 12.3×
FY 2016 5y median -14.6× FY 2025
EV/EBITDA 38.8×
FY 2016: -66.8×FY 2017: -38.4×FY 2018: -0.6×FY 2019: -16.7×FY 2020: -128×FY 2021: -24.4×FY 2022: -26.4×FY 2023: -72.7×FY 2024: -140×FY 2025: 38.8×
FY 2016 5y median -26.4× FY 2025
EV/Sales 7.9×
FY 2016: 746×FY 2017: 1238×FY 2018: 372×FY 2019: 25.1×FY 2020: 23.5×FY 2021: 13.5×FY 2022: 10.2×FY 2023: 7.7×FY 2024: 5.0×FY 2025: 7.9×
FY 2016 5y median 7.9× FY 2025
FCF Yield 8.1%
FY 2016: -1.7%FY 2017: -2.5%FY 2018: -18.3%FY 2019: -7.3%FY 2020: -1.2%FY 2021: -6.8%FY 2022: -7.5%FY 2023: -2.3%FY 2024: -0.8%FY 2025: 8.1%
FY 2016 5y median -2.3% FY 2025

Profitability

Gross Margin 86.5%
FY 2016: 100.0%FY 2017: 485.5%FY 2018: 113.8%FY 2019: 88.1%FY 2020: 89.9%FY 2021: 86.6%FY 2022: 79.6%FY 2023: 70.9%FY 2024: 84.0%FY 2025: 86.5%
FY 2016 5y median 84.0% FY 2025
Operating Margin 15.5%
FY 2016: -1436.6%FY 2017: -4046.5%FY 2018: -18841.8%FY 2019: -158.8%FY 2020: -14.5%FY 2021: -63.3%FY 2022: -68.5%FY 2023: -27.1%FY 2024: -8.0%FY 2025: 15.5%
FY 2016 5y median -27.1% FY 2025
Net Margin 6.2%
FY 2016: -1569.4%FY 2017: -3033.3%FY 2018: -60900.0%FY 2019: -164.2%FY 2020: -26.0%FY 2021: -63.9%FY 2022: -47.8%FY 2023: -16.6%FY 2024: -1.0%FY 2025: 6.2%
FY 2016 5y median -16.6% FY 2025
ROE 4.1%
FY 2016: 36.4%FY 2017: 28.9%FY 2018: -137.6%FY 2019: -36.2%FY 2020: -11.4%FY 2021: -26.4%FY 2022: -20.3%FY 2023: -8.2%FY 2024: -0.7%FY 2025: 4.1%
FY 2016 5y median -8.2% FY 2025
ROIC 6.4%
FY 2016: -12.2%FY 2017: -21.5%FY 2018: -32.8%FY 2019: -26.7%FY 2020: -5.2%FY 2021: -19.9%FY 2022: -20.8%FY 2023: -8.7%FY 2024: -4.3%FY 2025: 6.4%
FY 2016 5y median -8.7% FY 2025
ROA 2.1%
FY 2016: -17.9%FY 2017: -22.9%FY 2018: -94.4%FY 2019: -23.8%FY 2020: -8.4%FY 2021: -16.8%FY 2022: -12.4%FY 2023: -5.0%FY 2024: -0.4%FY 2025: 2.1%
FY 2016 5y median -5.0% FY 2025

Growth (YoY)

Revenue 34.8%
FY 2016: 0.0%FY 2017: -42.3%FY 2018: -48.9%FY 2019: 10953.3%FY 2020: 266.9%FY 2021: 11.1%FY 2022: 6.7%FY 2023: 36.2%FY 2024: 51.8%FY 2025: 34.8%
FY 2016 FY 2025
Operating Income 360.5%
FY 2016: 0.0%FY 2017: -62.5%FY 2018: -138.0%FY 2019: 6.9%FY 2020: 66.5%FY 2021: -385.2%FY 2022: -15.5%FY 2023: 46.2%FY 2024: 55.0%FY 2025: 360.5%
FY 2016 FY 2025
EPS (diluted) 915.6%
FY 2016: 0.0%FY 2017: -11.1%FY 2018: -3348.0%FY 2019: 91.2%FY 2020: 51.0%FY 2021: -154.1%FY 2022: 22.3%FY 2023: 54.8%FY 2024: 91.5%FY 2025: 915.6%
FY 2016 FY 2025
Free Cash Flow 2327.1%
FY 2016: 0.0%FY 2017: -38.4%FY 2018: -127.8%FY 2019: -52.8%FY 2020: 46.8%FY 2021: -258.7%FY 2022: 14.8%FY 2023: 62.6%FY 2024: 66.1%FY 2025: 2327.1%
FY 2016 FY 2025

Financial Health

Current Ratio 2.6×
FY 2016: 24.6×FY 2017: 8.9×FY 2018: 7.0×FY 2019: 5.2×FY 2020: 6.4×FY 2021: 3.8×FY 2022: 3.3×FY 2023: 3.0×FY 2024: 2.4×FY 2025: 2.6×
FY 2016 5y median 3.0× FY 2025
Quick Ratio 2.5×
FY 2016: 24.1×FY 2017: 8.5×FY 2018: 6.9×FY 2019: 4.9×FY 2020: 5.9×FY 2021: 3.3×FY 2022: 2.9×FY 2023: 2.8×FY 2024: 2.2×FY 2025: 2.5×
FY 2016 5y median 2.8× FY 2025
Debt / Equity 0.1×
FY 2016: -0.4×FY 2017: -0.3×FY 2018: 0.2×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.2× FY 2025
Net Debt / EBITDA -5.7×
FY 2016: 1.4×FY 2017: 0.0×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 0.1×FY 2021: -0.5×FY 2022: -1.3×FY 2023: 9.7×FY 2024: 13.9×FY 2025: -5.7×
FY 2016 5y median -0.5× FY 2025
Interest Coverage 25.4×
FY 2016: -8.6×FY 2017: -13.1×FY 2018: -25.9×FY 2019: -28.0×FY 2020: -8.2×FY 2021: -43.3×FY 2022: -30.7×FY 2023: -17.0×FY 2024: -11.2×FY 2025: 25.4×
FY 2016 5y median -17.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31